• View Press Releases

    View Press Releases

News & Media

Recent News

View All News

Quick Facts

Year founded 1998

Nasdaq SGEN

Number of Employees ~1,200

Global Headquarters Bothell, WA

European Headquarters Zug, Switzerland

icon-sw.png

Primary Product ADCETRIS® (brentuximab vedotin)

adcetris.png

Disease Focus Areas Hodgkin lymphoma, non-Hodgkin lymphoma, urothelial cancer, breast cancer

heart.png

Clinical & preclinical pipeline programs 12+

ADCs in clinical trials using our technology 20+

Resources

Social Media

 

Media Contacts

For Media Professionals Only

Monique Greer, Vice President Corporate Communications

media@seagen.com